+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Cancer Drugs Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2024

  • ID: 4702608
  • Report
  • Region: Global
  • 100 pages
  • Infinium Global Research
1 of 3

FEATURED COMPANIES

  • Amgen Inc.
  • Bayer AG
  • CELGENE CORPORATION
  • Eli Lilly and Company
  • GlaxoSmithKline Plc.
  • Merck & Co., Inc.
  • MORE
The report on the global cancer drugs market provides qualitative and quantitative analysis for the period from 2016 to 2024. The report predicts the global cancer drugs market to grow with a CAGR of 7.2% over the forecast period from 2018-2024. The study on cancer drugs market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and RoW for the period of 2016 to 2024.

The report on the cancer drugs market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global cancer drugs market over the period of 2016 to 2024. Moreover, the report is a collective presentation of primary and secondary research findings.

Porter's five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global cancer drugs market over the period of 2016 to 2024. Further, the Growth Matrix gave in the report brings an insight into the investment areas that existing or new market players can consider.

Report Findings

1. Drivers
  • Growing Occurrence of Different Types of Cancer
  • Increasing Concerns related High Death Rates due to Cancer
  • Advancement in Cancer Treatment Technology
2. Restraints
  • High Cost of Cancer Treatments
3. Opportunities
  • Introduction of Novel Cancer Drugs Products
Research Methodology

Primary Research

Primary research involves extensive interviews and analysis of the opinions provided by the primary respondents. The primary research starts with identifying and approaching the primary respondents, the primary respondents are approached include:

1. Key Opinion Leaders associated

2. Internal and External subject matter experts

3. Professionals and participants from the industry

Primary research respondents typically include:

1. Executives working with leading companies in the market under review

2. Product/brand/marketing managers

3. CXO level executives

4. Regional/zonal/country managers

5. Vice President level executives.

Secondary Research

Secondary research involves extensive exploring through the secondary sources of information available in both the public domain and paid sources. Each research study is based on over 500 hours of secondary research accompanied by primary research. The information obtained through the secondary sources is validated through the crosscheck on various data sources.

Secondary sources of the data typically include:

1. Company reports and publications

2. Government/institutional publications

3. Trade and associations journals

4. Databases such as WTO, OECD, World Bank, and among others.

5. Websites and publications by research agencies

Segment Covered

The global cancer drugs market is segmented on the basis of types, and application.

The Global Cancer Drugs Market by Types
  • Breast Cancer
  • Gastrointestinal Cancer
  • Blood Cancer
  • Bladder Cancer
  • Liver Cancer
  • Lung And Bronchus Cancer
  • Skin Cancer
  • Others
The Global Cancer Drugs Market by Application
  • Immunotherapy
  • Targeted Therapy
  • Hormone Therapy
  • Chemotherapy
Company Profiles

The companies covered in the report include:
  • Bayer AG
  • Eli Lilly and Company
  • Novartis AG
  • Amgen Inc.
  • GlaxoSmithKline Plc.
  • Bristol-Myers Squibb Company
  • Pfizer Inc
  • Merck & Co., Inc.
  • CELGENE CORPORATION
  • Boehringer Ingelheim International GmbH
  • Sanofi
What does this report deliver?

1. Comprehensive analysis of the global as well as regional markets of the cancer drugs market.

2. Complete coverage of all the segments in the cancer drugs market to analyze the trends, developments in the global market and forecast of market size up to 2024.

3. Comprehensive analysis of the companies operating in the global cancer drugs market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.

4. The Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Amgen Inc.
  • Bayer AG
  • CELGENE CORPORATION
  • Eli Lilly and Company
  • GlaxoSmithKline Plc.
  • Merck & Co., Inc.
  • MORE
1. Preface
1.1. Report Description
1.2. Research Methods
1.3. Research Approaches

2. Executive Summary
2.1. Cancer Drugs Market Highlights
2.2. Cancer Drugs Market Projection
2.3. Cancer Drugs Market Regional Highlights

3. Global Cancer Drugs Market Overview
3.1. Introduction
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.3. Porter's Five Forces Analysis
3.4. Growth Matrix Analysis
3.4.1. Growth Matrix Analysis by Types
3.4.2. Growth Matrix Analysis by Application
3.4.3. Growth Matrix Analysis by Region
3.5. Value Chain Analysis of Cancer Drugs Market

4. Cancer Drugs Market Macro Indicator Analysis

5. Global Cancer Drugs Market by Types
5.1. Breast Cancer
5.2. Gastrointestinal Cancer
5.3. Blood Cancer
5.4. Bladder Cancer
5.5. Liver Cancer
5.6. Lung And Bronchus Cancer
5.7. Skin Cancer
5.8. Others

6. Global Cancer Drugs Market by Application
6.1. Immunotherapy
6.2. Targeted Therapy
6.3. Hormone Therapy
6.4. Chemotherapy

7. Global Cancer Drugs Market by Region 2018-2024
7.1. North America
7.1.1. North America Cancer Drugs Market by Types
7.1.2. North America Cancer Drugs Market by Application
7.1.3. North America Cancer Drugs Market by Country
7.2. Europe
7.2.1. Europe Cancer Drugs Market by Types
7.2.2. Europe Cancer Drugs Market by Application
7.2.3. Europe Cancer Drugs Market by Country
7.3. Asia-Pacific
7.3.1. Asia-Pacific Cancer Drugs Market by Types
7.3.2. Asia-Pacific Cancer Drugs Market by Application
7.3.3. Asia-Pacific Cancer Drugs Market by Country
7.4. RoW
7.4.1. RoW Cancer Drugs Market by Types
7.4.2. RoW Cancer Drugs Market by Application
7.4.3. RoW Cancer Drugs Market by Sub-region

8. Company Profiles and Competitive Landscape
8.1. Competitive Landscape in the Global Cancer Drugs Market
8.2. Companies Profiles
8.2.1. Bayer AG
8.2.1.1. Overview
8.2.1.2. Company Snapshot
8.2.1.3. Financial Snapshot
8.2.1.4. Product Portfolio
8.2.1.5. Recent Developments
8.2.2. Eli Lilly and Company
8.2.2.1. Overview
8.2.2.2. Company Snapshot
8.2.2.3. Financial Snapshot
8.2.2.4. Product Portfolio
8.2.2.5. Recent Developments
8.2.3. Novartis AG
8.2.3.1. Overview
8.2.3.2. Company Snapshot
8.2.3.3. Financial Snapshot
8.2.3.4. Product Portfolio
8.2.3.5. Recent Developments
8.2.4. Amgen Inc.
8.2.4.1. Overview
8.2.4.2. Company Snapshot
8.2.4.3. Financial Snapshot
8.2.4.4. Product Portfolio
8.2.4.5. Recent Developments
8.2.5. GlaxoSmithKline plc.
8.2.5.1. Overview
8.2.5.2. Company Snapshot
8.2.5.3. Financial Snapshot
8.2.5.4. Product Portfolio
8.2.5.5. Recent Developments
8.2.6. Bristol-Myers Squibb Company
8.2.6.1. Overview
8.2.6.2. Company Snapshot
8.2.6.3. Financial Snapshot
8.2.6.4. Product Portfolio
8.2.6.5. Recent Developments
8.2.7. Pfizer Inc.
8.2.7.1. Overview
8.2.7.2. Company Snapshot
8.2.7.3. Financial Snapshot
8.2.7.4. Product Portfolio
8.2.7.5. Recent Developments
8.2.8. Merck & Co., Inc.
8.2.8.1. Overview
8.2.8.2. Company Snapshot
8.2.8.3. Financial Snapshot
8.2.8.4. Product Portfolio
8.2.8.5. Recent Developments
8.2.9. CELGENE CORPORATION
8.2.9.1. Overview
8.2.9.2. Company Snapshot
8.2.9.3. Financial Snapshot
8.2.9.4. Product Portfolio
8.2.9.5. Recent Developments
8.2.10. Boehringer Ingelheim International GmbH
8.2.10.1. Overview
8.2.10.2. Company Snapshot
8.2.10.3. Financial Snapshot
8.2.10.4. Product Portfolio
8.2.10.5. Recent Developments
8.2.11. Sanofi
8.2.11.1. Overview
8.2.11.2. Company Snapshot
8.2.11.3. Financial Snapshot
8.2.11.4. Product Portfolio
8.2.11.5. Recent Developments

9. Appendix
9.1. Primary Research Findings and Questionnaire
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Bayer AG
  • Eli Lilly and Company
  • Novartis AG
  • Amgen Inc.
  • GlaxoSmithKline Plc.
  • Bristol-Myers Squibb Company
  • Pfizer Inc
  • Merck & Co., Inc.
  • CELGENE CORPORATION
  • Boehringer Ingelheim International GmbH
  • Sanofi
Note: Product cover images may vary from those shown
Adroll
adroll